Representative Image NEW DELHI: Two more vaccines for the COVID-19 and a new pill to treat people with mild-to-moderate symptoms…
SII to supply 10 million doses of Covishield to UK NEW DELHI: The United Kingdom (UK) will receive 10 million…
Bangladesh obtained two million doses of COVID-19 vaccine from the Serum Institute of India (SII) on Tuesday, February 23. NEW…
Representative Image NEW DELHI: The Government of India had approved two made-in-India vaccines, Covishield and Covaxin, manufactured by the Serum…
Bharat Biotech requests emergency use licence for COVID-19 vaccine NEW DELHI: Bharat Biotech, a Hyderabad- based pharmaceutical firm, requested emergency…
Representative Image NEW DELHI: AZD1222, Oxford University and AstraZeneca’s COVID vaccine candidate, is considered to be one of the first…
Representative Image NEW DELHI: The Pune-based Serum Institute of India (SII) will start Phase 2 human clinical trial of an…